AI Article Synopsis
- U-VATS is shown to be equally effective as triportal VATS for treating primary spontaneous pneumothorax (PSP), with no significant differences in recurrence rates or postoperative complications.
- Significant benefits of U-VATS include reduced necessity for further access, shorter chest tube duration, and a shorter postoperative hospital stay.
- U-VATS also resulted in lower pain scores, reduced pain duration, and better cosmetic outcomes compared to triportal VATS, making it a less invasive option for patients.
Article Abstract
Background: The role of triportal video-assisted thoracoscopic surgery (VATS) is widely recognized for the treatment of primary spontaneous pneumothorax (PSP). The aim of this study was to assess the effectiveness and the potential advantages of uniportal VATS (U-VATS) for the treatment of PSP compared with triportal VATS.
Methods: A total of 104 triportal (n=39) and uniportal (n=65) VATS procedures where performed for the treatment of PSP in two University hospitals. The prospectively collected data of postoperative outcomes were retrospectively reviewed and a 1:1 propensity score matching analysis was performed to compare the two VATS approaches.
Results: No major adverse events occurred after operation. Compared with triportal-VATS, Uniportal-VATS showed the same effectiveness in terms of risk of recurrence (null in both groups), post-operative complications (P=1.000) and operating time (66.04±16.92 74.57±21.38 min, P=0.141). However, there was a statistically significant difference in favor of uniportal-VATS in terms of necessity of further access [0 7 (30.4%), P=0.004], chest tube duration (4.39±1.41 6.32±0.94 days, P<<0.001), postoperative hospital stay (4.78±1.31 6.61±1.67 days, P<<0.001), visual analogue pain score (VAS) at 24 hours (3.45±1.41 6.44±2.45, P<<0.001), number of patients who had pain after chest drain removal [1 (4.3%) 16 (69.6%), P<<0.001], VAS after drainage removal (0.11±0.47 2.74±2.25, P<<0.001), postoperative pain duration (2.50±1.20 14.82±37.41 days, P<<0.001), pain killers intake (0.75±1.06 7.53±3.96 days, P=0.001), chronic paresthesia (level scale: 0 to 2; 0 0.52±0.66, P<<0.001), chronic neuralgia (0 0.43±0.59, P<<0.001) and cosmetic results (level scale: 0 to 3; 2.91±0.28 2.00±0.77, P<<0.001).
Conclusions: U-VATS is feasible and safe and may be a less invasive alternative to triportal VATS for the treatment of PSP because of its effectiveness in reducing postoperative pain, paresthesia, hospital stay and in improving cosmetic results.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258640 | PMC |
| http://dx.doi.org/10.21037/jtd.2018.04.124 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mini-Invasive Thoracic Surgery for Early-Stage Lung Cancer: Which Is the Surgeon's Best Approach for Video-Assisted Thoracic Surgery?
J Clin Med
October 2024
Department of Thoracic Surgery, Sant'Andrea Hospital, Sapienza University, 00189 Rome, Italy.
The choice of the best Video-Assisted Thoracic Surgery (VATS) surgical approach is still debated. Surgeons are often faced with the choice between innovation and self-confidence. The present study reports the experience of a high-volume single institute, comparing data of uni-portal, bi-portal and tri-portal VATS, to find out the safest and most effective mini-invasive approach, leading surgeon's choice.
View Article and Find Full Text PDFGiant Thoracic Meningocele: A Multidisciplinary Surgical Approach with Innovative Exclusion Technique.
World Neurosurg
September 2024
Neurosurgery Department, Santa Maria delle Grazie Hospital, Naples, Italy.
Thoracic meningocele is a rare medical condition that is usually linked to neurofibromatosis type I. Respiratory and neurologic symptoms characterize it. Although there have been some improvements in surgical techniques, the condition has a high recurrence rate, with most cases recurring within a year of surgery.
View Article and Find Full Text PDFAneurysmal artery supplying pulmonary sequestration: successful combined approach.
Interdiscip Cardiovasc Thorac Surg
May 2024
Thoracic Surgery Unit, Department of Surgical Sciences, Santa Maria della Misericordia Hospital, University of Perugia Medical School, Perugia, Italy.
A 62-year-old man was diagnosed with an asymptomatic intralobar pulmonary sequestration supplied by a short-neck proximal 57×25 mm aneurysmal artery originating from the mid-descending aorta. The patient underwent thoracic endovascular aneurysm repair; an aortic endograft was released to entirely restore the aberrant vessel. Then, pulmonary resection was performed.
View Article and Find Full Text PDFUniportal Video-Assisted Thoracoscopic Surgery Completion Lobectomy Long after Wedge Resection or Segmentectomy in the Same Lobe: A Bicenter Study.
Cancers (Basel)
March 2024
Department of General Thoracic Surgery, Fondazione Policlinico Gemelli IRCCS, Catholic University of Sacred Heart of Rome, 00168 Rome, Italy.
Background: Completion lobectomy (CL) following a prior resection in the same lobe may be complicated by severe pleural or hilar adhesions. The role of uniportal video-assisted thoracoscopic surgery (U-VATS) has never been evaluated in this setting.
Methods: Data were collected from two Italian centers.
Perioperative outcomes of robotic-assisted versus video-assisted thoracoscopic lobectomy: A propensity score matched analysis.
Thorac Cancer
July 2023
Department of Thoracic Surgery, Peking University Cancer Hospital, Beijing, China.
Background: The existing literature on perioperative outcomes of robotic-assisted thoracoscopic surgery (RATS) versus video-assisted thoracoscopic surgery (VATS) for lung lobectomy is inconclusive.
Methods: We conducted a retrospective cohort analysis of VATS and RATS lobectomy procedures for patients with non-small cell lung cancer to compare the short-term perioperative outcomes by propensity score matching (PSM) analysis.
Results: A total of 418 patients were enrolled in this study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!